* Przedstawione definicje mają na celu standaryzację badań klinicznych i muszą być interpretowane w kontekście danej sytuacji klinicznej.

ARDS (adult respiratory distress syndrome) – zespół ostrej niewydolności oddechowej; DIC (disseminated intravascular coagulation) – zespół rozsianego wykrzepiania wewnątrznaczyniowego; GCS (Glasgow Coma Scale) – skala śpiączki Glasgow; Hb (hemoglobin) – hemoglobina; HCT (haematocrit) – hematokryt

Piśmiennictwo:

1. Smith AD, Bradley DJ, Smith V, et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987–2006. BMJ 2008;337:a120.

2. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008;46:165-71.

3. Pasvol G. Cell-cell interaction in the pathogenesis of severe falciparum malaria. Clin Med 2001;1:495-500.

4. Severe falciparum malaria. World Health Organization Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000;94(Suppl 1):S1-90.

5. Lalloo DG, Shingadia D, Pasvol G, et al. UK malaria treatment guidelines. J Infect 2007;54:111-21.

6. Phillips A, Bassett P, Zeki S, et al. Risk factors for severe disease in adults with falciparum malaria. Clin Infect Dis 2009;48:871-8.

7. Bruneel F, Tubach F, Corne P, et al. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One 2010;5:e13236.

8. Marsh K, Forster D,Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-404.

9. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983;309:61-6.

10. Berkley J, Mwarumba S, Bramham K, et al. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg 1999;93:283-6.

11. Karanikas G, Zedwitz-Liebenstein K, Eidherr H, et al. Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients. Thromb Haemost 2004;91:553-7.

12. Clemens R, Pramoolsinsap C, Lorenz R, et al. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol 1994;87:100-5.

13. Tran TH, Day NP, Ly VC, et al. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis 1996;23:1274-81.

14. Kremsner PG, Valim C, Missinou MA, et al. Prognostic value of circulating pigmented cells in African children with malaria. J Infect Dis 2009;199:142-50.

15. Murray CK, Gasser RA Jr, Magill AJ, et al. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008;21:97-110.

16. Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States: a systematic review. JAMA 2007;297:2264-77.

17. Dondorp A, Nosten F, Stepniewska K, et al; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366:717-25.

18. Dondorp AM, Fanello CI, Hendriksen IC, et al; AQUAMAT group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010;376:1647-57.

19. Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N Engl J Med 2008;358:1829-36.

20. Riddle MS, Jackson JL, Sanders JW, et al. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 2002;34:1192-8.

21. Wilkinson RJ, Brown JL, Pasvol G, et al. Severe falciparum malaria: predicting the effect of exchange transfusion. QJM 1994;87: 553-7.

Do góry